Found: 10
Select item for more details and to access through your institution.
Driver Mutations and Single Copy Number Abnormalities Identify Binet Stage A Patients with Chronic Lymphocytic Leukemia with Aggressive Progression.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 11, p. 3695, doi. 10.3390/jcm9113695
- By:
- Publication type:
- Article
NK Cells in the Treatment of Hematological Malignancies.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 10, p. 1557, doi. 10.3390/jcm8101557
- By:
- Publication type:
- Article
Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 5, p. 797, doi. 10.1111/bjh.15713
- By:
- Publication type:
- Article
Impact of pre- and/or post-autologous stem cell transplantation exposure to brentuximab vedotin on survival outcomes in patients with high-risk Hodgkin lymphoma.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 429, doi. 10.1007/s00277-022-05011-6
- By:
- Publication type:
- Article
BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2529, doi. 10.1007/s00262-023-03435-1
- By:
- Publication type:
- Article
The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling.
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.02455
- By:
- Publication type:
- Article
Chemo-Immunotherapy: A New Trend in Cancer Treatment.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 2912, doi. 10.3390/cancers15112912
- By:
- Publication type:
- Article
LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2112, doi. 10.3390/cancers13092112
- By:
- Publication type:
- Article
BTLA/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic Leukemia.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1766, doi. 10.3390/cancers13081766
- By:
- Publication type:
- Article
NK Cell-Based Immunotherapy in Cancer Metastasis.
- Published in:
- Cancers, 2019, v. 11, n. 1, p. 29, doi. 10.3390/cancers11010029
- By:
- Publication type:
- Article